Tokyo, Aug. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062430) titled 'Epithelial immune remodeling underlies CRSwNP pathophysiology and tezepelumab restores epithelial function' on Aug. 1.
Study Type:
Interventional
Study Design:
Basic Design - Parallel
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - No treatment
Primary Sponsor:
Institute - Dokkyo Medical University
Condition:
Condition - Chronic rhinosinusitis with nasal polyps
Classification by malignancy - Others
Genomic information - YES
Objective:
Narrative objectives1 - 1. To determine whether tezepelumab restores epithelial homeostasis and normalizes epithelial immune remodeling in patients with ...